Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (11-20 of 474) with videos related to

Pageof 48
Sort By:
The Medico-Legal Journal|January 28, 2017
The changing prostate cancer pathway - new challenges, new pitfallsMark Emberton
The Lancet. Oncology|January 18, 2017
Is a negative prostate biopsy a risk factor for a prostate cancer related death?Mark Emberton
BJU International|November 27, 2019
Translating cost-utility modelling into the real world - the case of focal high-intensity focussed ultrasound and active surveillanceMark Emberton
The Journal of Urology|July 18, 2015
Why Focal Therapy is a Legitimate and Necessary Response to a Changing WorldMark Emberton
BJU International|March 2, 2006
Definition of at-risk patients: dynamic variablesMark Emberton
BJU International|April 25, 2018
Has tailored, tissue-selective tumour ablation in men with prostate cancer come of age?Mark Emberton
European Urology|December 20, 2025
Is Prostate-specific Antigen a Useful Triage Test Before Prostate Magnetic Resonance Imaging?Mark Emberton
Nature Reviews. Urology|March 15, 2019
To see or not to see - what renders prostate cancer visible?Mark Emberton
BJU International|July 20, 2019
Dropping the GAD - just a fad? The case for a simpler, quicker, safer and cheaper prostate magnetic resonance imagingMark Emberton
Current Opinion in Urology|December 31, 2005
To what extent do real life practice studies differ from randomized controlled trials in lower urinary tract symptoms/benign prostatic hyperplasia?Vibhash Mishra, Mark Emberton
Pageof 48

Showing results (11-20 of 474) with videos related to

Sort By:
Pageof 48
The Medico-Legal Journal|January 28, 2017
The changing prostate cancer pathway - new challenges, new pitfallsMark Emberton
The Lancet. Oncology|January 18, 2017
Is a negative prostate biopsy a risk factor for a prostate cancer related death?Mark Emberton
BJU International|November 27, 2019
Translating cost-utility modelling into the real world - the case of focal high-intensity focussed ultrasound and active surveillanceMark Emberton
The Journal of Urology|July 18, 2015
Why Focal Therapy is a Legitimate and Necessary Response to a Changing WorldMark Emberton
BJU International|March 2, 2006
Definition of at-risk patients: dynamic variablesMark Emberton
BJU International|April 25, 2018
Has tailored, tissue-selective tumour ablation in men with prostate cancer come of age?Mark Emberton
European Urology|December 20, 2025
Is Prostate-specific Antigen a Useful Triage Test Before Prostate Magnetic Resonance Imaging?Mark Emberton
Nature Reviews. Urology|March 15, 2019
To see or not to see - what renders prostate cancer visible?Mark Emberton
BJU International|July 20, 2019
Dropping the GAD - just a fad? The case for a simpler, quicker, safer and cheaper prostate magnetic resonance imagingMark Emberton
Current Opinion in Urology|December 31, 2005
To what extent do real life practice studies differ from randomized controlled trials in lower urinary tract symptoms/benign prostatic hyperplasia?Vibhash Mishra, Mark Emberton
Pageof 48